Galectin Therapeutics Inc. (GALT) Ownership

$1.31

south_east
-$0.01 (-0.76%)
Day's range
$1.29
Day's range
$1.33

Galectin Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/13/2024 2.13 M $5.87 M   0.86% 3.43%
BLACKROCK FUNDING, INC. /DE 11/13/2024 1.61 M $4.42 M   100.00% 2.58%
AFFINITY ASSET ADVISORS, LLC 11/13/2024 1.21 M $3.33 M   100.00% 1.95%
ADVISOR GROUP HOLDINGS, INC. 11/13/2024 1.18 M $3.25 M   4.98% 1.90%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 862,542 $2.37 M   2.47% 1.39%
IKARIAN CAPITAL, LLC 11/14/2024 500,000 $1.38 M   100.00% 0.80%
COMMONWEALTH EQUITY SERVICES, LLC 10/18/2024 483,264 $1.33 M   -0.02% 0.78%
WEALTHSPIRE ADVISORS, LLC 11/13/2024 398,374 $1.10 M   0.00% 0.64%
GENEOS WEALTH MANAGEMENT INC. 11/14/2024 352,935 $970,571   -10.36% 0.57%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 291,700 $802,175   -69.87% 0.47%
STATE STREET CORP 11/14/2024 251,014 $690,289   9.32% 0.40%
MORGAN STANLEY 11/14/2024 246,080 $676,721   8.30% 0.40%
NORTHERN TRUST CORP 11/13/2024 234,280 $644,270   84.51% 0.38%
ATRIA WEALTH SOLUTIONS, INC. 11/08/2024 207,100 $569,525   -3.13% 0.33%
CAPTION MANAGEMENT, LLC 11/14/2024 155,000 $426,250   100.00% 0.25%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2024 146,200 $402,050   100.00% 0.23%
SOLTIS INVESTMENT ADVISORS LLC 01/03/2025 140,750 $387,063   100.00% 0.23%
CUTTER & CO BROKERAGE, INC. 10/25/2024 115,488 $317,592   0.00% 0.19%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 10/28/2024 114,720 $315,000   2.31% 0.18%
LPL FINANCIAL LLC 11/08/2024 81,908 $225,247   -6.13% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 81,467 $224,034   -59.74% 0.13%
11/25/2024 79,113 $219,934   -21.40% 0.13%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 65,073 $178,951   0.00% 0.10%
RETIREMENT GUYS FORMULA LLC 10/21/2024 63,817 $175,497   55.06% 0.10%
CITADEL ADVISORS LLC 11/14/2024 62,500 $171,875   359.56% 0.10%
ADAR1 CAPITAL MANAGEMENT, LLC 11/14/2024 55,300 $152,075   100.00% 0.09%
MARSHALL WACE, LLP 11/14/2024 52,259 $143,712   177.60% 0.08%
CITADEL ADVISORS LLC 11/14/2024 51,600 $141,900   1,811.11% 0.08%
HORIZON KINETICS ASSET MANAGEMENT LLC 11/13/2024 51,484 $141,581   -4.20% 0.08%
SYNOVUS FINANCIAL CORP 11/25/2024 48,000 $132,000   0.00% 0.08%
TRAYNOR CAPITAL MANAGEMENT, INC. 10/25/2024 42,871 $117,896   0.00% 0.07%
BANK OF NEW YORK MELLON CORP 11/12/2024 42,721 $117,483   -33.69% 0.07%
KOVITZ INVESTMENT GROUP PARTNERS, LLC 11/15/2024 42,540 $116,985   100.00% 0.07%
STRATOS WEALTH PARTNERS, LTD. 10/17/2024 40,450 $111,238   0.00% 0.07%
BLAIR WILLIAM & CO/IL 11/12/2024 37,884 $104,181   0.00% 0.06%
MILLENNIUM MANAGEMENT LLC 11/14/2024 36,372 $100,023   -31.78% 0.06%
SOLUTIONS 4 WEALTH, LTD 11/14/2024 36,003 $99,008   -0.23% 0.06%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 10/24/2024 35,098 $96,520   0.54% 0.06%
GOLDMAN SACHS GROUP INC 11/14/2024 33,032 $90,838   46.40% 0.05%
D.A. DAVIDSON & CO. 11/13/2024 30,771 $84,620   -36.91% 0.05%
JPMORGAN CHASE & CO 12/26/2024 30,628 $84,227   161.31% 0.05%
EXODUSPOINT CAPITAL MANAGEMENT, LP 11/12/2024 29,552 $81,000   100.00% 0.05%
BARCLAYS PLC 11/19/2024 28,587 $79,000   309.03% 0.05%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 27,623 $75,963   0.00% 0.04%
SQUAREPOINT OPS LLC 11/14/2024 27,435 $75,446   -67.37% 0.04%
MARINER, LLC 11/13/2024 26,585 $73,109   0.41% 0.04%
VIVALDI CAPITAL MANAGEMENT LP 11/14/2024 24,032 $66,088   0.00% 0.04%
BEACON CAPITAL MANAGEMENT, LLC 11/07/2024 23,905 $65,739   0.00% 0.04%
GLADSTONE INSTITUTIONAL ADVISORY LLC 10/28/2024 21,750 $59,813   100.00% 0.03%
SUMMIT TRAIL ADVISORS, LLC 11/12/2024 20,000 $55,000   0.00% 0.03%

Galectin Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 106 institutional investors and hedge funds held shares of Galectin Therapeutics Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 1.65 M

ADVISOR GROUP HOLDINGS, INC.: 1.18 M

Wealthspire Advisors, LLC: 398,374

Geneos Wealth Management Inc.: 388,935

Atria Wealth Solutions, Inc.: 207,100

RETIREMENT GUYS FORMULA LLC: 155,343

15.65% of Galectin Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 13.01 M shares in the last 24 months. This purchase volume represents approximately $17.05 M in transactions.